Mechanisms of action of anticonvulsant agents

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Systematic screening of many compounds in animal models led to identification of the established antiepileptic drugs (AEDs). By contrast, the newer AEDs were specifically designed to enhance an inhibitory process or to inhibit a specific excitatory pathway. However, it was later discovered that some of the designed drugs differed in their modes of action from what was envisioned. Recently, it has become apparent that all AEDs, old and new, may affect sodium and calcium channels, increase brain concentration of free γ-aminobutyric acid (GABA), and reduce glutamate-mediated excitation by inhibiting N-methyl-D-aspartate (NMDA) and the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors. However, not all the drugs affect all of these mechanisms. Understanding the modes of action of each drug may explain why some of them are effective in treating other neurologic and neuropsychiatric disorders. This understanding may make it possible to develop a group of neuroexcitatory amino acid transmitter antagonists with intended antiepileptogenic actions.

Original languageEnglish (US)
JournalNeurology
Volume55
Issue number5 SUPPL. 1
StatePublished - 2000

Fingerprint

Anticonvulsants
Pharmaceutical Preparations
Aminobutyrates
Isoxazoles
AMPA Receptors
Sodium Channels
N-Methylaspartate
Calcium Channels
Nervous System Diseases
gamma-Aminobutyric Acid
Glutamic Acid
Animal Models
Amino Acids
Brain
propionic acid

Keywords

  • Antiepileptic drugs
  • Gamma-aminobutyric acid
  • Mechanisms of action

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Mechanisms of action of anticonvulsant agents. / Moshe, Solomon L.

In: Neurology, Vol. 55, No. 5 SUPPL. 1, 2000.

Research output: Contribution to journalArticle

@article{f0e4ef270ba745d49d1ea333a4c507b0,
title = "Mechanisms of action of anticonvulsant agents",
abstract = "Systematic screening of many compounds in animal models led to identification of the established antiepileptic drugs (AEDs). By contrast, the newer AEDs were specifically designed to enhance an inhibitory process or to inhibit a specific excitatory pathway. However, it was later discovered that some of the designed drugs differed in their modes of action from what was envisioned. Recently, it has become apparent that all AEDs, old and new, may affect sodium and calcium channels, increase brain concentration of free γ-aminobutyric acid (GABA), and reduce glutamate-mediated excitation by inhibiting N-methyl-D-aspartate (NMDA) and the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors. However, not all the drugs affect all of these mechanisms. Understanding the modes of action of each drug may explain why some of them are effective in treating other neurologic and neuropsychiatric disorders. This understanding may make it possible to develop a group of neuroexcitatory amino acid transmitter antagonists with intended antiepileptogenic actions.",
keywords = "Antiepileptic drugs, Gamma-aminobutyric acid, Mechanisms of action",
author = "Moshe, {Solomon L.}",
year = "2000",
language = "English (US)",
volume = "55",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "5 SUPPL. 1",

}

TY - JOUR

T1 - Mechanisms of action of anticonvulsant agents

AU - Moshe, Solomon L.

PY - 2000

Y1 - 2000

N2 - Systematic screening of many compounds in animal models led to identification of the established antiepileptic drugs (AEDs). By contrast, the newer AEDs were specifically designed to enhance an inhibitory process or to inhibit a specific excitatory pathway. However, it was later discovered that some of the designed drugs differed in their modes of action from what was envisioned. Recently, it has become apparent that all AEDs, old and new, may affect sodium and calcium channels, increase brain concentration of free γ-aminobutyric acid (GABA), and reduce glutamate-mediated excitation by inhibiting N-methyl-D-aspartate (NMDA) and the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors. However, not all the drugs affect all of these mechanisms. Understanding the modes of action of each drug may explain why some of them are effective in treating other neurologic and neuropsychiatric disorders. This understanding may make it possible to develop a group of neuroexcitatory amino acid transmitter antagonists with intended antiepileptogenic actions.

AB - Systematic screening of many compounds in animal models led to identification of the established antiepileptic drugs (AEDs). By contrast, the newer AEDs were specifically designed to enhance an inhibitory process or to inhibit a specific excitatory pathway. However, it was later discovered that some of the designed drugs differed in their modes of action from what was envisioned. Recently, it has become apparent that all AEDs, old and new, may affect sodium and calcium channels, increase brain concentration of free γ-aminobutyric acid (GABA), and reduce glutamate-mediated excitation by inhibiting N-methyl-D-aspartate (NMDA) and the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors. However, not all the drugs affect all of these mechanisms. Understanding the modes of action of each drug may explain why some of them are effective in treating other neurologic and neuropsychiatric disorders. This understanding may make it possible to develop a group of neuroexcitatory amino acid transmitter antagonists with intended antiepileptogenic actions.

KW - Antiepileptic drugs

KW - Gamma-aminobutyric acid

KW - Mechanisms of action

UR - http://www.scopus.com/inward/record.url?scp=0033818259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033818259&partnerID=8YFLogxK

M3 - Article

C2 - 11001360

AN - SCOPUS:0033818259

VL - 55

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 5 SUPPL. 1

ER -